(Q73574723)

English

The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets

scientific article published on 01 February 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

F D Tattersall

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

W Rycroft

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Cumberbatch

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

G Mason

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Tye

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D J Williamson

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J J Hale

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S G Mills

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P E Finke

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M MacCoss

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Sadowski

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

E Ber

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Cascieri

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R G Hill

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D E MacIntyre

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R J Hargreaves

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 February 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

number of pages

12

1 reference

based on heuristic

inferred from page(s)

Neuropharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

39

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

652-663

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

The pharmacology of the emetic response to upper gastrointestinal tract stimulation in Suncus murinus

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The tachykinin NK1 receptor antagonist GR205171 abolishes the retching activity of neurons comprising the central pattern generator for vomiting in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The site of the anti-emetic action of tachykinin NK1 receptor antagonists may exist in the medullary area adjacent to the semicompact part of the nucleus ambiguus.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Broad spectrum antiemetic effects of CP-122,721, a tachykinin NK1 receptor antagonist, in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Potent inhibition of both the acute and delayed emetic responses to cisplatin in piglets treated with GR205171, a novel highly selective tachykinin NK1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Dexamethasone can potentiate the anti-emetic action of a 5HT3 receptor antagonist on cyclophosphamide induced vomiting in the ferret

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The effect of CP-99994 on the responses to provocative motion in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Skeletal muscle afferent fibres release substance P in the nucleus tractus solitarii of anaesthetized cats.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Effects of 5-HT3 receptor antagonists on models of acute and delayed emesis induced by cisplatin in the ferret.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The interaction of dexamethasone with ondansetron on drug-induced emesis in the ferret

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Characterization of the binding of [125I-iodo-histidyl, methyl-Phe7] neurokinin B to the neurokinin-3 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Drug treatment of chemotherapy-induced delayed emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Initial high anti-emetic efficacy of granisetron with dexamethasone is not maintained over repeated cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Identifiers

10.1016/S0028-3908(99)00172-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73574723&oldid=1786248824"